Redeye: Northbaze - Heading into 2024 with excitement
Redeye updates on Northbaze following Q4 results, which were weaker than expected on the topline but in line with our EBITDA forecasts. With the acquisition of Skalhuset last December, Redeye anticipates an exciting 2024 for Northbaze. The company's outlook remains uncertain due to persistent challenges in the market, leading to adjustments in our estimates and a downward revision of the valuation range
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/